Gofen & Glossberg Llc decreased Teva Pharmaceutical Ind Adr (TEVA) stake by 41.06% reported in 2017Q3 SEC filing. Gofen & Glossberg Llc sold 27,776 shares as Teva Pharmaceutical Ind Adr (TEVA)’s stock declined 15.11%. The Gofen & Glossberg Llc holds 39,875 shares with $702,000 value, down from 67,651 last quarter. Teva Pharmaceutical Ind Adr now has $19.04 billion valuation. The stock decreased 3.41% or $0.66 during the last trading session, reaching $18.72. About 13.33 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since March 1, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.
As exposed in the U.S. Security & Exchange Commission, a report for the transaction of 23,223 shares of Dunkin’ Brands Group Inc by Nigel Travis was filled. Nigel Travis serves as a CEO & Chairman of the ‘s company. The public document was filled on February 28, 2018. The shares were unloaded at average $62.0 per share, and had a market value of $1,440,755 US Dollars, making this transaction an extremely significant one. He also sold 326,777 shares with a total value $20,335,015 USD in the last month. Having been a very substantial market deal at Dunkin’ Brands Group Inc, the chance that it stays a secret for long was obviously very low. Nigel Travis right now holds 274,898 shares which make up roughly 0.30% of the Massachusetts-Company’s total market cap.
Analysts await Teva Pharmaceutical Industries Limited (NYSE:TEVA) to report earnings on May, 10. They expect $0.64 earnings per share, down 37.86% or $0.39 from last year’s $1.03 per share. TEVA’s profit will be $650.80 million for 7.31 P/E if the $0.64 EPS becomes a reality. After $0.91 actual earnings per share reported by Teva Pharmaceutical Industries Limited for the previous quarter, Wall Street now forecasts -29.67% negative EPS growth.
Gofen & Glossberg Llc increased Ishares Msci Eafe Index Fd (EFA) stake by 10,888 shares to 195,542 valued at $13.39 million in 2017Q3. It also upped Chubb Ltd stake by 3,545 shares and now owns 62,120 shares. Bank Of America (NYSE:BAC) was raised too.
Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 146 analyst reports since July 21, 2015 according to SRatingsIntel. Credit Suisse maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Monday, November 6 with “Underperform” rating. The company was upgraded on Tuesday, January 31 by Bank of America. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Neutral” rating by Nomura on Tuesday, September 29. Leerink Swann maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, January 26 with “Sell” rating. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Neutral” rating by Goldman Sachs on Friday, July 15. Barclays Capital maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Friday, October 20. Barclays Capital has “Equal-Weight” rating and $19 target. The firm earned “Hold” rating on Wednesday, October 4 by Mizuho. The stock has “Hold” rating by Jefferies on Thursday, June 22. Wells Fargo initiated Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, February 19 with “Outperform” rating. As per Monday, July 18, the company rating was upgraded by HSBC.
Analysts await Dunkin' Brands Group, Inc. (NASDAQ:DNKN) to report earnings on May, 3. They expect $0.51 earnings per share, down 5.56% or $0.03 from last year’s $0.54 per share. DNKN’s profit will be $46.06 million for 29.36 P/E if the $0.51 EPS becomes a reality. After $0.64 actual earnings per share reported by Dunkin' Brands Group, Inc. for the previous quarter, Wall Street now forecasts -20.31% negative EPS growth.
Among 30 analysts covering Dunkin Brands (NASDAQ:DNKN), 15 have Buy rating, 3 Sell and 12 Hold. Therefore 50% are positive. Dunkin Brands has $78.0 highest and $42 lowest target. $58.63’s average target is -2.10% below currents $59.89 stock price. Dunkin Brands had 85 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Wednesday, April 20 by Nomura. The rating was maintained by Maxim Group on Thursday, November 19 with “Buy”. Nomura maintained the stock with “Neutral” rating in Tuesday, January 30 report. The firm has “Sell” rating given on Tuesday, October 10 by Jefferies. Maxim Group maintained it with “Buy” rating and $54 target in Tuesday, February 2 report. Barclays Capital maintained the shares of DNKN in report on Tuesday, January 16 with “Buy” rating. The company was upgraded on Friday, December 22 by Jefferies. The company was maintained on Tuesday, November 29 by Credit Suisse. On Monday, October 26 the stock rating was maintained by UBS with “Neutral”. Maxim Group maintained Dunkin' Brands Group, Inc. (NASDAQ:DNKN) rating on Tuesday, September 27. Maxim Group has “Buy” rating and $57 target.
Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.25, from 1.42 in 2017Q2. It turned negative, as 31 investors sold Dunkin' Brands Group, Inc. shares while 93 reduced holdings. 53 funds opened positions while 92 raised stakes. 80.37 million shares or 2.04% less from 82.04 million shares in 2017Q2 were reported. Advsrs Asset Management stated it has 3,107 shares or 0% of all its holdings. Ubs Asset Management Americas holds 0% or 71,986 shares. Griffin Asset Mgmt holds 0.36% or 37,415 shares in its portfolio. Engineers Gate Manager Lp stated it has 38,852 shares or 0.17% of all its holdings. Amer Research And Mgmt Co reported 200 shares. M&T Commercial Bank Corp invested in 10,837 shares. Carnegie Capital Asset Ltd Liability Corporation has invested 0.5% in Dunkin' Brands Group, Inc. (NASDAQ:DNKN). Wells Fargo & Mn has invested 0.01% in Dunkin' Brands Group, Inc. (NASDAQ:DNKN). Legal & General Gru Public Ltd Co holds 0% of its portfolio in Dunkin' Brands Group, Inc. (NASDAQ:DNKN) for 82,606 shares. Cipher Limited Partnership invested 0.08% in Dunkin' Brands Group, Inc. (NASDAQ:DNKN). 22,675 were accumulated by Cls Investments Limited Com. Gotham Asset Management Ltd Co accumulated 0.03% or 33,400 shares. Howe Rusling reported 0% of its portfolio in Dunkin' Brands Group, Inc. (NASDAQ:DNKN). Oppenheimer & Com Inc has invested 0.02% in Dunkin' Brands Group, Inc. (NASDAQ:DNKN). 51,133 are owned by Arizona State Retirement.
The stock decreased 2.30% or $1.41 during the last trading session, reaching $59.89. About 1.48 million shares traded or 39.30% up from the average. Dunkin' Brands Group, Inc. (NASDAQ:DNKN) has risen 27.29% since March 1, 2017 and is uptrending. It has outperformed by 10.59% the S&P500.
Dunkin?? Brands Group, Inc., together with its subsidiaries, develops, franchises, and licenses quick service restaurants under the Dunkin?? Donuts and Baskin-Robbins brands worldwide. The company has market cap of $5.41 billion. The firm operates through four divisions: Dunkin?? Donuts U.S., Dunkin?? Donuts International, Baskin-Robbins International, and Baskin-Robbins U.S. It has a 15.76 P/E ratio. The Company’s restaurants offer hot and cold coffee, baked goods, donuts, bagels, muffins, breakfast sandwiches, hard-serve ice cream, soft serve ice cream, frozen yogurt, shakes, malts, floats, and cakes.
The post Why Nigel Travis Unloaded 23,223 Stock of Dunkin' Brands Group, Inc. (DNKN)?; Gofen & Glossberg Cut By $472,192 Its Teva Pharmaceutical Ind Adr (TEVA) Holding appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/03/01/why-nigel-travis-unloaded-23223-stock-of-dunkin-brands-group-inc-dnkn-gofen-glossberg-cut-by-472192-its-teva-pharmaceutical-ind-adr-teva-holding/
No comments:
Post a Comment